Li Zhishu, Chen Jiayue, Zeng Jia, Shi Ping, Xiong Xiaomin, Wang Meng, Zheng Dong, Zhao Rui, Dong Lixia
Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Department of Respiratory and Critical Care Medicine, Guangyuan Central Hospital, Guangyuan, People's Republic of China.
Infect Drug Resist. 2023 Feb 17;16:1009-1018. doi: 10.2147/IDR.S400838. eCollection 2023.
In patients with tuberculous pleural effusion (TPE) of various ages, the diagnostic accuracy of pleural biomarkers varies, and there are insufficient studies specifically in different age groups. Therefore, we investigated the adenosine deaminase cut-off value and its combination with the gamma interferon release assay for the diagnosis of TPE among patients aged ≥40 years.
A retrospective analysis of 198 patients who underwent medical thoracoscopy and were admitted to the hospital between 2015 and 2020 with exudative pleural effusion and either fever, night sweats, fatigue, cough, or other clinical manifestations was performed. The medical thoracoscopy, ADA, and T-SPOT results were analysed in the pleural fluid. The patients were divided into groups based on age: 18-39, 40-59, and 60-87.
The best cut-off values of ADA were 29.5, 31.5 and 19.5 U/L, respectively, for the aged 18-39, aged 40-87 and aged 60-87 groups. The accuracy of 31.5 U/L was higher than 40 U/L for aged ≥40 years (86 vs 83%). The ADA diagnostic accuracy was higher than that of people under 40 years (83 vs 77%) when cut-off value of ADA was 40 U/L, but the IGRA accuracy was lower than that of people under 40 (87 vs 91%). The sensitivity of ADA or IGRA detection in patients over 40 years was 99%, and the specificity was 78%. The ADA specificity combined with IGRA for TPE was the highest (100%) in the ≥40 age group, and the sensitivity was 69%.
Our study revealed the best cut-off values of ADA for TBE in different age groups. Combining ADA and IGRA in pleural fluid improves the detection rate of TPE in patients over 40 years of age with exudative pleural effusion. ADA combined with IGRA increases specificity, and ADA or IGRA increases sensitivity substantially.
在不同年龄段的结核性胸腔积液(TPE)患者中,胸膜生物标志物的诊断准确性各不相同,且针对不同年龄组的专门研究不足。因此,我们研究了腺苷脱氨酶(ADA)的临界值及其与γ干扰素释放试验联合用于诊断年龄≥40岁患者的TPE情况。
对198例接受内科胸腔镜检查且在2015年至2020年间因渗出性胸腔积液伴发热、盗汗、乏力、咳嗽或其他临床表现入院的患者进行回顾性分析。对胸腔积液中的内科胸腔镜检查、ADA和T-SPOT结果进行分析。患者按年龄分为三组:18 - 39岁、40 - 59岁和60 - 87岁。
ADA的最佳临界值在18 - 39岁组、40 - 87岁组和60 - 87岁组分别为29.5、31.5和19.5 U/L。对于年龄≥40岁的患者,31.5 U/L的准确性高于40 U/L(分别为86%和83%)。当ADA临界值为40 U/L时,ADA的诊断准确性高于40岁以下人群(分别为83%和77%),但γ干扰素释放试验(IGRA)的准确性低于40岁以下人群(分别为87%和91%)。40岁以上患者中ADA或IGRA检测的敏感性为99%,特异性为78%。在≥40岁年龄组中,ADA特异性与IGRA联合用于TPE诊断时最高(100%),敏感性为69%。
我们的研究揭示了不同年龄组TBE中ADA的最佳临界值。胸腔积液中ADA与IGRA联合可提高40岁以上渗出性胸腔积液患者TPE的检出率。ADA与IGRA联合可提高特异性,ADA或IGRA可显著提高敏感性。